KOD. thx Dew ...I scaled back my position earlier in favor of those Co's where trial read outs are less likely to be delayed by COVID . Any opinion on ARVN . They released an ASCO abstract tonight showing 2 of 8 patients responded well . AH trades indicate markets disappointed but CMO is pointing out that for the 2 patients that responded well .....had previously tried all available therapies with little benefit. . CMO says these results supports dose escalation Kiwi
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.